Evidence map›Paper›PMID 32321479›Full record

ArticleBMC psychiatry2020

Comprehensive phenotyping of neuropsychiatric traits in a multiplex 3q29 deletion family: a case report.

Melissa M Murphy, T Lindsey Burrell, Joseph F Cubells, Michael T Epstein, Roberto Espana, Michael J Gambello, Katrina Goines, Cheryl Klaiman, Sookyong Koh, Rossana Sanchez Russo and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Deep phenotyping in 3q29 deletion syndrome: recommendations for clinical care.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Melissa M MurphyDepartment of Human Genetics, Emory University School of Medicine, Whitehead 305M, 615 Michael Street, Atlanta, GA, 30322, USA.
T Lindsey BurrellDepartment of Pediatrics, Emory University School of Medicine, Atlanta, USA.
Joseph F CubellsDepartments of Human Genetics and Psychiatry and Behavioral Science, Emory University School of Medicine, Atlanta, USA.
Michael T EpsteinDepartment of Psychiatry and Behavioral Science, Emory University School of Medicine, Atlanta, USA.
Roberto EspanaDepartment of Psychology, Emory University, Atlanta, USA.
Michael J GambelloDepartment of Human Genetics, Emory University School of Medicine, Whitehead 305M, 615 Michael Street, Atlanta, GA, 30322, USA.
Katrina GoinesDepartment of Psychology, Emory University, Atlanta, USA.
Cheryl KlaimanDepartment of Pediatrics, Emory University School of Medicine, Atlanta, USA.
Sookyong KohDepartment of Pediatrics, Emory University School of Medicine, Atlanta, USA.
Rossana Sanchez RussoDepartment of Human Genetics, Emory University School of Medicine, Whitehead 305M, 615 Michael Street, Atlanta, GA, 30322, USA.
Celine A SaulnierDepartment of Pediatrics, Emory University School of Medicine, Atlanta, USA.
Elaine WalkerDepartment of Psychology, Emory University, Atlanta, USA.
Emory 3q29 Project
Jennifer Gladys MulleDepartment of Human Genetics, Emory University School of Medicine, Whitehead 305M, 615 Michael Street, Atlanta, GA, 30322, USA. jmulle@emory.edu.
Emory University · US

Funding

Modeling the Human Neuronal Phenotype of the Schizophrenia-Associated 3q29 deletionR01MH110701 · NIMH · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI BASSELL, GARY J, MULLE, JENNIFER GLADYS · 2017 to 2021
$3.2M
NIMH NIH HHS R01 MH110701
6 · The paper itself

Abstract

background3q29 deletion syndrome is associated with a range of medical, neurodevelopmental, and psychiatric phenotypes. The deletion is usually de novo but cases have been reported where the deletion is inherited from apparently unaffected parents. The presence of these unaffected or mildly affected individuals suggests there may be an ascertainment bias for severely affected cases of 3q29 deletion syndrome, thus the more deleterious consequence of the 3q29 deletion may be overestimated. However, a substantial fraction of 3q29 deletion syndrome morbidity is due to psychiatric illness. In many case reports, probands and transmitting parents are not systematically evaluated for psychiatric traits. Here we report results from a systematic phenotyping protocol for neurodevelopmental and neuropsychiatric traits applied to all 3q29 deletion carriers in a multiplex family. CASE PRESENTATION: Through the 3q29 registry at Emory University, a multiplex family was identified where three offspring had a paternally inherited 3q29 deletion. We evaluated all 4 3q29 deletion family members using our previously described standardized, systematic phenotyping protocol. The transmitting parent reported no psychiatric history, however upon evaluation he was discovered to meet criteria for multiple psychiatric diagnoses including previously undiagnosed schizoaffective disorder. All four 3q29 deletion individuals in the pedigree had multiple psychiatric diagnoses that interfered with quality of life and prohibited successful academic and occupational functioning. Cognitive ability for all individuals was average or below average, but within the normal range.

conclusionsThis is the first case report of inherited 3q29 deletion syndrome where all affected individuals in the pedigree have been comprehensively and systematically evaluated for neurodevelopmental and psychiatric symptoms, using a standard battery of normed instruments administered by expert clinicians. Our investigation reveals that individuals with 3q29 deletion syndrome may have psychiatric morbidity that is debilitating, but only apparent through specialized evaluation by an expert. In the absence of appropriate evaluation, individuals with 3q29 deletion syndrome may suffer from psychiatric illness but lack avenues for access to care. The individuals evaluated here all have cognition in the normal range alongside multiple psychiatric diagnoses each, suggesting that cognitive ability alone is not a representative proxy for 3q29 deletion-associated disability. These results require replication in a larger cohort of individuals with 3q29 deletion syndrome.

Indexed as

PedigreeChromosome DeletionChromosomes, Human, Pair 3Developmental DisabilitiesHumansIntellectual DisabilityMaleMental DisordersPhenotypePsychotic DisordersQuality of LifeSyndrome3q29 deletionADHDCase ReportCNV disorderEvaluation of genetic syndromesPsychosisSchizophrenia

Identifiers

PMID32321479
PMCPMC7179007
OpenAlexW3020309558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.